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1. Table 2          S2 


































Table 2: List of amino acids considered to be part of the arylpiperazine binding site in the D2 DAR and 5HT1A receptor. 
 




ASP 114 ASP 116 3.32 
SER 167  4.57 
ILE 166  4.58 
LEU 170  4.61 
LEU 171  4.62 
ASN 175  4.66 
PHE 189  5.38 
VAL 190  5.39 
 SER 199 5.42 
SER 194 THR 200 5.43 
SER 197  5.46 
 PHE 204 5.47 
TRP 386 TRP 358 6.48 
 PHE 361 6.51 
PHE 390 PHE 362 6.52 
ILE 397  6.59 
HIS 398  6.60 





























Conformational energy diagram for compounds 4a, 6a and 7a 
 
 
Figure 1: Conformational energy diagram for compound 4a 
 
Figure 2: Conformational energy diagram for compound 6a 
 
 
Figure 3: Conformational energy diagram for compound 7a 
 
 
 
